Revenue segments as reported by the company.

Premiums

Product revenue

Administrative fees and other revenue

Net investment income

Net gains on financial instruments

Impairment losses on investments

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Benefit expense

Selling, general and administrative

Interest expense

Amortization of other intangible assets

Loss on extinguishment of debt

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Anthem

Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. The firm supports consumers, families, and communities across the entire care journey, connecting them to the care, support, and resources they need to lead healthier lives. It offers health plans and clinical, behavioral, pharmacy, and complex-care solutions which promote whole health. The company was founded in 1944 and is headquartered in Indianapolis, IN.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. It operates through the following segments: Commercial and Specialty Business, Government Business, CarelonRx, and Other. The Commercial and Specialty Business segment provides insurance products and services such as stop loss, dental, vision, life, disability and supplemental health insurance. The Government Business segment includes medicare and medicaid businesses, national government services, and services provided to the federal government. The CerelonRx segment offers formulary management, pharmacy networks, prescription drug database, member services, and mail order capabilities. The Other segment is involved in health services business focused on quality of healthcare by enabling and creating new care delivery and payment models. The company was founded in 1944 and is headquartered in Indianapolis, IN.

INDIANAPOLIS--(BUSINESS WIRE)--Please replace the release with the following corrected version due to multiple revisions to the first and second paragraph. The updated release reads: ANTHEM OFFERING FINANCIAL INCENTIVES TO ENCOURAGE ALL ASSOCIATES TO RECEIVE COVID-19 VACCINATION Anthem, Inc. (NYSE: ANTM) today announced that it will provide an incentive to all associates who are fully vaccinated against COVID-19. With vaccines now the focal point of combatting the pandemic, Anthem recognizes th

CORRECTING and REPLACING Anthem Offering Financial Incentives to Encourage All Associates to Receive COVID-19 Vaccination

Anthem Inc. said Wednesday it will pay a $50 incentive to any of its employees who are fully vaccinated against COVID-19. The health insurer said the incentive will be in the form of a one-time credit toward medical premiums or a donation to the Anthem Cares Fund that helps support fellow employees in need, at the employees choice.

Anthem to provide all employees with $50 incentive to be fully vaccinated against COVID-19

INDIANAPOLIS--(BUSINESS WIRE)--Anthem, Inc. (NYSE: ANTM) today announced that it will provide a $50 incentive to all associates who are fully vaccinated against COVID-19. With vaccines now the focal point of combatting the pandemic, Anthem recognizes the critical role Anthem plays in ensuring safe and equitable access to the vaccines in our communities. Anthem Associates who are fully vaccinated against COVID-19 can choose to receive a one-time $50 credit toward medical premiums or donate the c

Anthem Offering Financial Incentives to Encourage All Associates to Receive COVID-19 Vaccination

CVS Health

UnitedHealth Group

By Robert Ross Things are finally starting to calm down here in California. After a major surge in COVID-19 cases over the holidays, cases are back down to where they were in fall 2020: Source: The New York Times We have the successful vaccination rollout to thank for most of the decline.

These 3 Digital Care Stocks Aren't Going Anywhere but Up

Anthem's (ANTM) weak balance sheet and steep expenses will likely keep the stock stressed.

Here's Why You Should Stay Away From Anthem (ANTM) Right Now

Anthem (ANTM) to purchase at-home provider, benefits coordinator, myNEXUS, to provide better in-home care.

Anthem (ANTM) to Buy myNEXUS to Boost Homehealth Business

Assured Guaranty

Auburn National Bancorporation

Blackrock Inc

Commerce Bancshares

Cogent Communications Holdings

CME Group

Core-Mark Holding Company

Equity LifeStyle Properties

Franco-Nevada C

Horizon

Healthcare Services Group

Home Depot

International Flavors & Fragrances

Independent Bank

Jack Henry & Associates

Lithia Motors

L3Harris

LeMaitre Vascular

Lockheed Martin

Main Street Capital

Medtronic

Monro

Altria

Insperity

A weekly summary of dividend activity for Dividend Champions and Contenders. Companies which changed their dividends.

Dividend Champion And Contender Highlights: Week Of March 21

BioMarin Pharmaceutical

General Electric

American Outdoor Brands

American Water Works

CRISPR Therapeutics

Charles Schwab

Wheaton Precious Metals

Yext

With the trading day about halfway over, the broad markets had managed to push higher on the day, despite dipping into the red earlier.

Anthem, BioMarin, CRISPR, GE and More Thursday Afternoon Analyst Calls

Bausch Health Companies Inc

DuPont de Nemours

Norfolk Southern

Takeda Pharmaceutical

Tenet Healthcare

Glenview Capital Management recently disclosed its portfolio updates for the fourth quarter of 2020, which ended on Dec. 31.

The Top New Buys of Larry Robbins' Firm

Anthem (ANTM) reported earnings 30 days ago. What's next for the stock?

Anthem (ANTM) Down 0.1% Since Last Earnings Report: Can It Rebound?

Humana

Merck

Vertex Pharmaceuticals

With the markets setting all-time highs again and the first quarter soon to begin winding down, investors may be pondering how to position themselves for the rest of the year.

5 Health Care Laggards With Healthy Upside Potential

In this article, I'm taking a look at more of a dividend growth stock, as opposed to a higher yield stock. Anthem only yields 1.5%, but the company is qualitative. I consider Anthem to be one of the more interesting picks in its field, and its current valuation warrants at the very least a look from you.

Anthem: Do Not Miss This Opportunity

INDIANAPOLIS--(BUSINESS WIRE)--Anthem, Inc. (NYSE: ANTM) will host its virtual Investor Day conference on March 3, 2021. The event will feature presentations and a Q&A session with the Company's leadership team. The conference will be webcast live and all interested parties are invited to access the webcast at www.antheminc.com under the “Investors” link. The conference will begin at 8:30 a.m. Eastern Standard Time (“EST”) and conclude by 12:00 p.m. EST. To listen to the live webcast, pleas

Anthem to Host Virtual Investor Day Conference on March 3, 2021

Archer-Daniels-Midland Company

Arthur J. Gallagher & Co.

Air Products and Chemicals

Church & Dwight

Comcast

Canadian National Railway Company

Kimberly-Clark

MarketAxess Holdings

This weekly article series covers dividend changes. A summary table provides relevant data and key statistics of dividend increases.

Dividend Changes: January 23-29, 2021

Anthem (ANTM) acquires subsidiaries of InnovaCare Health in a bid to facilitate improved health outcomes across Puerto Rico.

Anthem's (ANTM) Buyout to Offer Better Healthcare in Puerto Rico

Cigna

A managed care juggernaut is quietly getting ready to compete with (and beat) industry heavyweights.

Recent Acquisitions Are Positioning This Healthcare Stock to Shine

Anthem is buying a Puerto Rico health plan's Medicaid and Medicare Advantage operations for an undisclosed sum from InnovaCare Health.

Anthem To Buy Puerto Rico Health Plan's Medicare And Medicaid Business

INDIANAPOLIS--(BUSINESS WIRE)--Anthem, Inc. (NYSE:ANTM) today announced that the company has entered into an agreement with InnovaCare Health, L.P., to acquire its Puerto Rico-based subsidiaries, including MMM Holdings, LLC (“MMM”) and its Medicare Advantage (MA) plan MMM Healthcare, LLC as well as affiliated companies and Medicaid plan. “We are pleased to expand Anthem's commitment to serve Medicare and Medicaid-eligible individuals and consumers to Puerto Rico. We remain focused on providing

Anthem, Inc. to Acquire MMM Holdings, LLC and Affiliates From InnovaCare Health, L.P.

Anthem's (ANTM) CEO Gail Boudreaux on Q4 2020 Results - Earnings Call Transcript

Shares of health insurance provider Anthem Inc. (NYSE:ANTM) fell more than 5% on Wednesday morning. Before the opening bell, the company announced fourth-quarter 2020 revenue and earnings that beat analysts' expectations.

Is Anthem's Pullback an Opportunity to Buy?

Frequency Therapeutics

Vir Biotechnology

Vir Biotechnology (NASDAQ: VIR) shares are trading lower Wednesday after JPMorgan downgraded the stock from Neutral to Underweight and announced a price target of $30 per share. Vir Biotechnology is a clinical-stage immunology company focused on treating and preventing infectious diseases.

Why Anthem, Frequency Therapeutics And Vir Are Moving Today

Anthem's (ANTM) fourth-quarter results benefit from higher revenues stemming from robust Medicaid and Medicare businesses, partly offset by higher costs.

Anthem (ANTM) Q4 Earnings Miss Estimates, Revenues Up Y/Y

Higher spending related to the COVID-19 pandemic hurt the big health insurer despite solid revenue growth.

Why Anthem Disappointed With Its Q4 Results

Health insurer Anthem's profits fell 41% in the fourth quarter of last year as Americans returned to get healthcare services they had put off earlier in the year due to the Covid-19 pandemic.

Anthem Blue Cross Profits Fall As Pandemic Medical Costs Rise

Anthem (ANTM) delivered earnings and revenue surprises of -1.17% and 2.25%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

Anthem (ANTM) Misses Q4 Earnings Estimates

News for Anthem Stock (ANTM)